(Q36102276)

12 August 2017

1 reference

title

The role of bisphosphonates in the treatment of prostate cancer (English)

1 reference

12 August 2017

1 reference

Christopher C Parker

1

1 reference

12 August 2017

publication date

1 May 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

95

1 reference

12 August 2017

issue

7

1 reference

12 August 2017

page(s)

935-938

1 reference

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05441.X

A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05441.X

Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05441.X

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05441.X

Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05441.X

10.1111/J.1464-410X.2005.05441.X

21 January 2018

Identifiers

DOI

1 reference

release_hga2mmgp6fcnpft7kapkx7znbi

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hga2mmgp6fcnpft7kapkx7znbi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference